Pharmacological and clinical implications of local anaesthetic mixtures: a narrative review
- PMID: 34904711
- DOI: 10.1111/anae.15641
Pharmacological and clinical implications of local anaesthetic mixtures: a narrative review
Abstract
Various techniques have been explored to prolong the duration and improve the efficacy of local anaesthetic nerve blocks. Some of these involve mixing local anaesthetics or adding adjuncts. We did a literature review of studies published between 01 May 2011 and 01 May 2021 that studied specific combinations of local anaesthetics and adjuncts. The rationale behind mixing long- and short-acting local anaesthetics to hasten onset and extend duration is flawed on pharmacokinetic principles. Most local anaesthetic adjuncts are not licensed for use in this manner and the consequences of untested admixtures and adjuncts range from making the solution ineffective to potential harm. Pharmaceutical compatibility needs to be established before administration. The compatibility of drugs from the same class cannot be inferred and each admixture requires individual review. Precipitation on mixing (steroids, non-steroidal anti-inflammatory drugs) and subsequent embolisation can lead to serious adverse events, although these are rare. The additive itself or its preservative can have neurotoxic (adrenaline, midazolam) and/or chondrotoxic properties (non-steroidal anti-inflammatory drugs). The prolongation of block may occur at the expense of motor block quality (ketamine) or block onset (magnesium). Adverse effects for some adjuncts appear to be dose-dependent and recommendations concerning optimal dosing are lacking. An important confounding factor is whether studies used systemic administration of the adjunct as a control to accurately identify an additional benefit of perineural administration. The challenge of how best to prolong block duration while minimising adverse events remains a topic of interest with further research required.
Keywords: admixtures; compatibility; local anaesthetics; pharmacodynamics; pharmacokinetics.
© 2021 Association of Anaesthetists.
References
-
- McCann ME. Liposomal bupivacaine. Anesthesiology 2021; 134: 139-42.
-
- Albrecht E, Chin KJ. Advances in regional anaesthesia and acute pain management: a narrative review. Anaesthesia 2020; 75: e101-e10.
-
- Murney P. To mix or not to mix - compatibilities of parenteral drug solutions. Australian Prescriber 2008; 31: 98-101.
-
- Pongraweewan O, Inchua N, Kitsiripant C, Kongmuang B, Tiwirach W. Onset time of 2% lidocaine and 0.5% bupivacaine mixture versus 0.5% bupivacaine alone using ultrasound and double nerve stimulation for infraclavicular brachial plexus anesthesia in ESRD patients undergoing arteriovenous fistula creation. Journal of the Medical Association of Thailand 2016; 99: 589-95.
-
- Almasi R, Rezman B, Kriszta Z, Patczai B, Wiegand N, Bogar L. Onset times and duration of analgesic effect of various concentrations of local anesthetic solutions in standardized volume used for brachial plexus blocks. Heliyon 2020; 6: e04718.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
